메뉴 건너뛰기




Volumn 16, Issue 3, 1999, Pages 251-256

Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis

Author keywords

Acute nonlymphoblastic leukemia; Langerhans cell histiocytosis; Outcome; Treatment

Indexed keywords

ALKYLATING AGENT; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; INTERCALATING AGENT; MERCAPTOPURINE; METHOTREXATE; STEROID; VINBLASTINE; VINCRISTINE;

EID: 0032915082     PISSN: 08880018     EISSN: None     Source Type: Journal    
DOI: 10.1080/088800199277317     Document Type: Article
Times cited : (19)

References (19)
  • 1
    • 0027419049 scopus 로고
    • Association of Langerhans cell histiocytosis with malignant neoplasms
    • Egeler RM, Neglia J, Pucetti DM, et al. Association of Langerhans cell histiocytosis with malignant neoplasms. Cancer. 1993;71:865-873.
    • (1993) Cancer , vol.71 , pp. 865-873
    • Egeler, R.M.1    Neglia, J.2    Pucetti, D.M.3
  • 2
    • 0028301082 scopus 로고
    • Acute leukemia in association with Langerhans cell histiocytosis
    • Egeler RM, Neglia JP, Arico M, et al. Acute leukemia in association with Langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:81-85.
    • (1994) Med Pediatr Oncol. , vol.23 , pp. 81-85
    • Egeler, R.M.1    Neglia, J.P.2    Arico, M.3
  • 3
    • 0028275643 scopus 로고
    • A treatment strategy for disseminated langerhans cell histiocytosis
    • Gadner H, Heitger A, Grois N, et al. A treatment strategy for disseminated langerhans cell histiocytosis. Med Pediatr Oncol. 1994;23:72-80.
    • (1994) Med Pediatr Oncol. , vol.23 , pp. 72-80
    • Gadner, H.1    Heitger, A.2    Grois, N.3
  • 4
    • 0026703948 scopus 로고
    • Vergleich der alleinigen chemotherapie mit der allogenen knochenmarkstransplantation in erster vollremission bei kindern mit akuter myeloischer leukämie in den studien AML-BFM-83 und AML-BFM-87
    • Creutzig U, Bender-Götze C, Klingebiel T, et al. Vergleich der alleinigen Chemotherapie mit der allogenen Knochenmarkstransplantation in erster Vollremission bei Kindern mit akuter myeloischer Leukämie in den Studien AML-BFM-83 und AML-BFM-87. Klin Pädiatr. 1992;204:246-252.
    • (1992) Klin Pädiatr. , vol.204 , pp. 246-252
    • Creutzig, U.1    Bender-Götze, C.2    Klingebiel, T.3
  • 5
    • 0028050043 scopus 로고
    • Verbesserung der lokalen tumorkontrolle durch einen frühen und risikoadaptierten einsatz der radiotherapie bei primär nicht resektablen rhabdomyosarkomen: Ergebnisse der CWS-81 und 86 studien
    • Koscielniak E, Herbst M, Niethammer T, Treuner J. Verbesserung der lokalen Tumorkontrolle durch einen frühen und risikoadaptierten Einsatz der Radiotherapie bei primär nicht resektablen Rhabdomyosarkomen: Ergebnisse der CWS-81 und 86 Studien. Klin Pädiatr. 1994;206:269-276.
    • (1994) Klin Pädiatr. , vol.206 , pp. 269-276
    • Koscielniak, E.1    Herbst, M.2    Niethammer, T.3    Treuner, J.4
  • 6
    • 0026607302 scopus 로고
    • Epipodophyllotoxins, alkylating agents and radiation and risk of secondary leukemia after childhood cancer
    • Hawkins MM, Kinnier Wilson LM, Stovall MA, et al. Epipodophyllotoxins, alkylating agents and radiation and risk of secondary leukemia after childhood cancer. BMJ. 1992;304:951-958.
    • (1992) BMJ , vol.304 , pp. 951-958
    • Hawkins, M.M.1    Kinnier Wilson, L.M.2    Stovall, M.A.3
  • 7
    • 0026584519 scopus 로고
    • Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure
    • Levine E, Bloomfield C. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Semin Oncol. 1992;19:47-84.
    • (1992) Semin Oncol. , vol.19 , pp. 47-84
    • Levine, E.1    Bloomfield, C.2
  • 8
    • 0021166099 scopus 로고
    • Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases
    • Pedersen-Bjegaard J, Philip P, Pedersen NT, et al. Acute nonlymphocytic leukemia, preleukemia, and acute myeloproliferative syndrome secondary to treatment of other malignant diseases. Cancer. 1984;54:452-462.
    • (1984) Cancer , vol.54 , pp. 452-462
    • Pedersen-Bjegaard, J.1    Philip, P.2    Pedersen, N.T.3
  • 9
    • 0028229192 scopus 로고
    • Acute promyelocytic leukemia in a patient treated with etoposide for Langerhans cell histiocytosis
    • Matsuzaki A, Inamitsu T, Watanabe T, et al. Acute promyelocytic leukemia in a patient treated with etoposide for Langerhans cell histiocytosis. Br J Haematol. 1994;86:887-889.
    • (1994) Br J Haematol. , vol.86 , pp. 887-889
    • Matsuzaki, A.1    Inamitsu, T.2    Watanabe, T.3
  • 10
    • 0028332667 scopus 로고
    • Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: Estimating the risk
    • Smith MA, Rubinstein L, Ungerleider RS. Therapy-related acute myeloid leukemia following treatment with epipodophyllotoxins: estimating the risk. Med Pediatr Oncol. 1994;23:86-98.
    • (1994) Med Pediatr Oncol. , vol.23 , pp. 86-98
    • Smith, M.A.1    Rubinstein, L.2    Ungerleider, R.S.3
  • 11
  • 12
    • 0027993777 scopus 로고
    • Treatment of Langerhans cell histiocytosis: Evolution and current approaches
    • Ladisch S, Gadner H. Treatment of Langerhans cell histiocytosis: evolution and current approaches. Br J Cancer. 1994;70:41-46.
    • (1994) Br J Cancer , vol.70 , pp. 41-46
    • Ladisch, S.1    Gadner, H.2
  • 13
    • 0030185202 scopus 로고    scopus 로고
    • Etoposide in Langerhans cell histiocytosis
    • Gadner H. Etoposide in Langerhans cell histiocytosis. Pediatr Hematol Oncol. 1996;13:309-311.
    • (1996) Pediatr Hematol Oncol. , vol.13 , pp. 309-311
    • Gadner, H.1
  • 14
    • 0022914279 scopus 로고
    • Therapy-related leukemia and myelodysplastic syndrome: Clinical, cytogenetic and prognostic features
    • Kantarjian HM, Keating MJ, Walters RS, et al. Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic and prognostic features. J Clin Oncol. 1986;4:1748-1757.
    • (1986) J Clin Oncol. , vol.4 , pp. 1748-1757
    • Kantarjian, H.M.1    Keating, M.J.2    Walters, R.S.3
  • 15
    • 0021797464 scopus 로고
    • Therapy-related acute myeloid leukemia and myelodysplastic syndrome: A clinical and morphologic study of 65 cases
    • Michels SD, McKenna RW, Arthur DC, Brunning RD. Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 cases. Blood. 1985;65:1364-1372.
    • (1985) Blood , vol.65 , pp. 1364-1372
    • Michels, S.D.1    McKenna, R.W.2    Arthur, D.C.3    Brunning, R.D.4
  • 16
    • 0345494954 scopus 로고
    • Acute promyelocytic leukemia following etoposide-based combination chemotherapy for Letterer-Siewe disease
    • Kitabayashi T, Sekiguchi N, Yanai M, et al. Acute promyelocytic leukemia following etoposide-based combination chemotherapy for Letterer-Siewe disease. Jpn J Pediatr Haematol. 1992;6:232-236.
    • (1992) Jpn J Pediatr Haematol. , vol.6 , pp. 232-236
    • Kitabayashi, T.1    Sekiguchi, N.2    Yanai, M.3
  • 17
    • 0027134789 scopus 로고
    • Acute promyelocytic leukemia with t (15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis
    • Horibe K, MatsushitaT, Shin-Ichiro N, et al. Acute promyelocytic leukemia with t (15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer. 1993;72:3723-3726.
    • (1993) Cancer , vol.72 , pp. 3723-3726
    • Horibe, K.1    Matsushita, T.2    Shin-Ichiro, N.3
  • 18
    • 0028018901 scopus 로고
    • Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis
    • Haupt R, Fears TR, Rosso P, et al. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans cell histiocytosis. Pediatr Hematol Oncol. 1994;11:499-507.
    • (1994) Pediatr Hematol Oncol. , vol.11 , pp. 499-507
    • Haupt, R.1    Fears, T.R.2    Rosso, P.3
  • 19
    • 0030932613 scopus 로고    scopus 로고
    • Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations
    • Haupt R, Fearf TR, Heise A, et al. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans cell histiocytosis in Italian and Austrian-German populations. Int J Cancer. 1997;71: 9-13.
    • (1997) Int J Cancer , vol.71 , pp. 9-13
    • Haupt, R.1    Fearf, T.R.2    Heise, A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.